EyePoint (EYPT) Interest Expenses (2011 - 2026)
EyePoint (EYPT) reported Interest Expenses of $32.9 million for Q1 2026, up 846.33% on a YoY basis from $3.5 million in Q1 2025, and up 2887.82% sequentially from $1.1 million in Q4 2025.
EyePoint (EYPT) Interest Expenses (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Interest Expenses data on file, last reported at $32.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 846.33% year-over-year to $32.9 million; the trailing twelve-month figure through Mar 2026 stood at $32.9 million (up 846.33% YoY), and the FY2025 full-year result was $73.2 million, up 878.44% from the prior year.
- Interest Expenses climbed to $32.9 million in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $72.4 million in Q2 2022 to a low of -$486000.0 in Q4 2024.
- A 5-year average of $28.8 million and a median of $22.6 million in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses soared 7872.91% in 2024 and tumbled 94.64% in 2025, its largest moves.
- Tracing EYPT's Interest Expenses over 5 years: stood at $781000.0 in 2022, then surged by 1236.36% to $10.4 million in 2023, then sank by 104.66% to -$486000.0 in 2024, then jumped by 326.34% to $1.1 million in 2025, then jumped by 2887.82% to $32.9 million in 2026.
- Business Quant data shows EYPT's Interest Expenses at $32.9 million in Q1 2026, $1.1 million in Q4 2025, and $45.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 32.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.87 Mn |
| Mar 31, 2026 | 32.87 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 45.50 Mn |
| Sep 30, 2025 | 45.50 Mn |
| Jun 30, 2025 | 46.59 Mn |
| Jun 30, 2025 | 46.59 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | -486,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Sep 30, 2024 | 47.75 Mn |
| Sep 30, 2024 | 47.75 Mn |
| Jun 30, 2024 | 48.60 Mn |
| Jun 30, 2024 | 48.60 Mn |
| Mar 31, 2024 | 64.74 Mn |
| Mar 31, 2024 | 64.74 Mn |
| Sep 30, 2023 | 10.44 Mn |
| Sep 30, 2023 | 10.44 Mn |